Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001571049-15-001225
Filing Date
2015-02-17
Accepted
2015-02-17 18:44:30
Documents
1
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT t1500369_x2-f5.html 5  
1 OWNERSHIP DOCUMENT t1500369_x2-f5.xml 5 3701
  Complete submission text file 0001571049-15-001225.txt   5335
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYCLACEL PHARMACEUTICALS, INC. 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address
Rombotis Spiro George (Reporting) CIK: 0001357396 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-50626 | Film No.: 15625049